222110 — Pangen Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSucker Stock

Annual balance sheet for Pangen Biotech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24,363	18,639	23,901	838	45.4
Net Total Accounts Receivable
Net Total Receivables	436	874	1,809	1,032	2,525
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	25,607	24,092	31,154	8,576	9,843
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,011	6,029	6,748	6,608	6,240
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	39,083	36,309	43,277	20,674	20,741
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18,907	20,091	19,886	1,130	5,711
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	20,657	22,098	22,179	3,454	8,175
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	18,426	14,211	21,098	17,219	12,566
Total Liabilities & Shareholders' Equity	39,083	36,309	43,277	20,674	20,741
Total Common Shares Outstanding